Saltar al contenido principal
Elsevier

Advances in Immunology

  • 1 Edición, Volumen 135 - 18 de agosto de 2017
  • Última edición
  • Editor: Frederick Alt
  • Idioma: Inglés

Advances in Immunology, Volume 135, the latest in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunolog… Leer más

Descripción

Advances in Immunology, Volume 135, the latest in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this latest update including chapters on GPCR Biology, the Role of Caveolin-1 in BCR and TCR Receptors, New Developments in the Chemokine Field, and The Complement System in Developmental Neurobiology and Neurodegeneration.

Readers will find comprehensive information on molecular and cellular activation mechanisms, phylogeny and molecular evolution and clinical modalities. Edited and authored by the foremost scientists in the field, each volume provides up-to-date information and directions for the future.

Puntos claves

  • Contains contributions from leading authorities in immunology Informs and updates on all the latest developments in the field of immunology

De interès para

Immunologists and infectious disease specialists, cell biologists and hematologists

Índice

1. Chromosome 17q21 Genes ORMDL3 and GSDMB in Asthma and Immune Diseases
Sudipta Das, Marina Miller and David H. Broide

2. Complement System in Neural Synapse Elimination in Development and Disease
Jessy Presumey, Allison R. Bialas and Michael C. Carroll

3. A Mechanistic Understanding of Pyroptosis: The Fiery Death Triggered by Invasive Infection
Xing Liu and Judy Lieberman

4. Chemokine-Driven CD4+ T Cell Homing: New Concepts and Recent Advances
Carly E. Gregor, Jade Foeng, Iain Comerford and Shaun R. McColl

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 135
  • Publicado: 30 de agosto de 2017
  • Idioma: Inglés

Sobre el editor

FA

Frederick Alt

Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Afiliaciones y experiencia
Professor of Pediatrics and Professor of Genetics, Harvard Medical School, Boston, MA, USA

Ver libro en ScienceDirect

Lee Advances in Immunology en ScienceDirect